Recent highlights of Sullivan & Cromwell's Middle East M&A and joint venture work include representing:
Teva Pharmaceutical in its $40.5 billion acquisition of Allergan Generics and its $50.5 billion unsolicited proposal for Mylan, later terminated.
Goldman Sachs, in its strategic cooperation arrangements with, and equity investment in, NCB Capital, the investment banking subsidiary of the National Commercial Bank of Saudi Arabia.
Abu Dhabi Future Energy, in its investment in WinWinD Oy, a wind turbines manufacturer.
AT&T, in connection with a mobile license bid in Qatar and in a confidential matter in the Gulf.
BP, as global coordinating counsel, in the $7 billion sale of its upstream assets in the United States, Canada and Egypt to Apache.
a financial institution, in a confidential joint venture arrangement in Saudi Arabia.
Mubadala Development, on European Commission competition matters, in its $8 billion commercial finance joint venture with General Electric.
DP World, in its sale of 100 percent of the outstanding stock of P&O Ports North America and PORTS Insurance to AIG Global Investment Group's infrastructure fund.
DP World, in the acquisition of the international terminals and port logistics business, primarily located in Hong Kong, China and Korea, from CSX.
an oil company controlled by a leading Saudi merchant family, in several M&A transactions.
a major Egyptian company, in connection with a multibillion dollar merger and another Egyptian company in connection with a multibillion dollar acquisition.
an Egyptian company, on the restructuring of a significant joint venture.
You may not collect more than 75 pages in a binder. Feel free to generate this binder, clear it, and start a new one with the additional pages you wish to collect.